Table 7. Unadjusted and adjusted predictors of being given SP by DOT amongst those who were given IPTp-SP in consultation at CSComs.

Potential predictors	SP DOT
	Unadjusted			Adjusted
	n	OR (95% CI)	p	OR (95% CI)	p
Socio-demographic
SES group
1 (poorest)	109	1.0	0.02	1.0	0.04
2 (very poor)	85	1.09 (0.41, 2.89)		1.16 (0.30, 4.48)
3 (poor)	84	0.37 (0.13, 1.10)		0.38 (0.10, 1.50)
4 (less poor)	41	0.29 (0.05, 1.70)		0.47(0.12, 1.81)
5 (least poor)	29	0.20 (0.02, 2.32)		0.45 (0.34, 5.97)
Process factors
Suggest a lab test
No	313	1.0	0.07	1.0	0.71
Yes	39	0.20 (0.03, 1.14)		1.67 (0.77, 36.48)
Presr syphilis test
No	328	1.0	0.03	1.0	0.16
Yes	26	0.07 (0.06, 0.78)		0.17 (0.01, 2.44)
Pay for consult
No	274	1.0	0.03	1.0	0.09
Yes	80	0.07 (0.01, 0.48)		0.12 (0.01, 1.52)
Money is spent
No	62	1.0	0.09	na
Yes	292	0.36 (0.11, 1.21)
Total money spent
<500	69	1.0	0.004	1.0	0.01
500–999	80	12.57 (2.25, 70.06)		9.87 (1.28, 75. 71)
≥1000	143	18.17 (5.10, 64.75)		12.17 (3.14,47.16)

Notes:

SP, Sulphadoxine-pyrimethamine; DOT, Direct Observed Treatment; n, number of events; OR, Odds Ratio, CI, Confidence Interval; SES, Socio-economic Status; Na, not available.